The personal nature of our science and our drive is supported by the perseverance to successfully discover, develop and commercialize cell therapies.

Our drive is to redefine how some of the most challenging-to-treat solid tumors are treated. Our proprietary cell therapy platform engineers a patient’s own cells to fight cancer.

With our robust pipeline of cell therapies, our goal is to, one day, significantly improve the patient’s treatment experience across a variety of solid tumor cancers.

Adaptimmune embraces this personalized approach from discovery through delivery with fully integrated capabilities including research, global clinical development, translational sciences, commercialization, and manufacturing.